NEJM June 2028 Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery

This clinical study investigates whether a routine hospital protocol for administering tranexamic acid can effectively and safely decrease the necessity for blood transfusions during major noncardiac operations. By comparing thousands of high-risk patients across various medical centers, researchers discovered that those receiving the medication were significantly less likely to require red-cell replacements than those given a placebo. Crucially, the data demonstrated that this treatment did not increase the frequency of venous thromboembolism, proving the drug's safety over a ninety-day period. Ultimately, the findings advocate for the systematic use of this therapy as a reliable method to conserve blood resources without compromising patient health.